JPRN-UMIN000047043招募中未知
eutralizing antibody titer after COVID-19 vaccination in Japanese elderly population - Neutralizing antibody titer after COVID-19 vaccination in Japanese elderly population
Medical Corporation, Forkmore0 个研究点目标入组 181 人开始时间: 2022年3月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 181
研究概览
简要总结
The geometric means of the first neutralizing antibody titer (NAT: AU/ml) were 645[49-8745] in OLD group (>= 65: N=119) and 1777 [159-19821] in YOUNG Group (< 65: N=62) respectively. The proportion of subjects (>=1280 AU/ml) were 39/119(32.8%) vs 39/62(62.9%) in the first measurement and 0/16(0.0%) vs 3/16(18.8%) in the second. Negative test results (<50) were 7/119(3.9%) vs (6/62(5.0%) vs 1/61(0.2%)) in the first NAT and (3/16(4.8%) vs 0/13(0.0%) in the second.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 12years-old 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •No signature of informed consent
研究者
相似试验
招募中
不适用
Neutralizing Antibody Level After COVID-19 VaccinationCovid19NCT05083026Kyungpook National University Hospital51
进行中(未招募)
1 期
Observation of antibody response in vacinated empoleyes after COVID-19 vaccine.antibody response following vaccine applicationMedDRA version: 20.1Level: PTClassification code 10060979Term: Antibody testSystem Organ Class: 10022891 - InvestigationsEUCTR2021-000633-14-CZStátní zdravotní ústav300
已完成
不适用
To study if BCG vaccinated individuals have enhanced COVID-19 antibodies after COVID-19 vaccination.CTRI/2022/10/046542I70
已完成
不适用
Protective Antibody Level After COVID-19 Vaccination Among Patients Under HemodialysisCovid19Vaccine ReactionHemolysisEnd-stage Renal DiseaseNCT04871945Hanyang University Seoul Hospital31
已完成
不适用
COVID-19 Antibody quantification and vaccination history and association with viral genotype (variant)COVID-19JPRN-UMIN000044519ihon University School of Medicine Itabashi Hospital2
